Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sarasin

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
The American Journal of Medicine|July 18, 2003
Electrocardiographic monitoring in the assessment of unexplained syncopeFrançois P Sarasin
Revue Medicale Suisse|September 13, 2005
[Emergencies: a challenge for health systems]François P Sarasin
QJM : Monthly Journal of the Association of Physicians|November 5, 1999
Decision analysis and the implementation of evidence-based medicineF P Sarasin
Revue Medicale Suisse|September 13, 2005
[Acute dyspnea: what is the diagnostic role of B-type natriuretic peptide?]F P Sarasin
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 13, 2001
Decision analysis and its application in clinical medicineF P Sarasin
Revue Medicale Suisse|December 22, 2005
[Should B-type natriuretic peptide (BNP) be used in daily practice?]F P Sarasin
Thrombosis and Haemostasis|May 15, 2002
Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysisFrançois P Sarasin, Henri Bounameaux
Thrombosis and Haemostasis|March 1, 1994
Duration of oral anticoagulant therapy after proximal deep vein thrombosis: a decision analysisF P Sarasin, H Bounameaux
Archives of Internal Medicine|August 12, 1996
Antithrombotic strategy after total hip replacement. A cost-effectiveness analysis comparing prolonged oral anticoagulants with screening for deep vein thrombosisF P Sarasin, H Bounameaux
Revue Medicale Suisse|November 21, 2007
[Efficacy and safety of probiotics]C Graf, F P Sarasin
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
The American Journal of Medicine|July 18, 2003
Electrocardiographic monitoring in the assessment of unexplained syncopeFrançois P Sarasin
Revue Medicale Suisse|September 13, 2005
[Emergencies: a challenge for health systems]François P Sarasin
QJM : Monthly Journal of the Association of Physicians|November 5, 1999
Decision analysis and the implementation of evidence-based medicineF P Sarasin
Revue Medicale Suisse|September 13, 2005
[Acute dyspnea: what is the diagnostic role of B-type natriuretic peptide?]F P Sarasin
European Journal of Obstetrics, Gynecology, and Reproductive Biology|February 13, 2001
Decision analysis and its application in clinical medicineF P Sarasin
Revue Medicale Suisse|December 22, 2005
[Should B-type natriuretic peptide (BNP) be used in daily practice?]F P Sarasin
Thrombosis and Haemostasis|May 15, 2002
Out of hospital antithrombotic prophylaxis after total hip replacement: low-molecular-weight heparin, warfarin, aspirin or nothing? A cost-effectiveness analysisFrançois P Sarasin, Henri Bounameaux
Thrombosis and Haemostasis|March 1, 1994
Duration of oral anticoagulant therapy after proximal deep vein thrombosis: a decision analysisF P Sarasin, H Bounameaux
Archives of Internal Medicine|August 12, 1996
Antithrombotic strategy after total hip replacement. A cost-effectiveness analysis comparing prolonged oral anticoagulants with screening for deep vein thrombosisF P Sarasin, H Bounameaux
Revue Medicale Suisse|November 21, 2007
[Efficacy and safety of probiotics]C Graf, F P Sarasin
Pageof 9